Pharmaceuticals: Going Price for Poison

Going Price for Poison

Edward Marks, 24, a former stockbroker trainee, admitted in an Orlando court last week that he had spiked Contac, Dietac and Teldrin capsule medicines with rat poison in a bid to make money in the stock market. Marks thus became the first person to plead guilty to charges of orchestrating a national drug- tampering scheme.

Marks poisoned capsules in a series of Orlando stores six months ago, after buying so-called put options in the stock of SmithKline Beckman, the manufacturer of all the non-prescription drugs. The option purchase would allow him to profit if SmithKline stock fell after the news of...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!